ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 138 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q4 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $671,173 | -18.7% | 26,269 | -8.7% | 0.00% | 0.0% |
| Q2 2023 | $825,496 | +16.6% | 28,783 | -2.6% | 0.00% | 0.0% |
| Q1 2023 | $708,050 | +39.2% | 29,539 | -1.5% | 0.00% | 0.0% |
| Q4 2022 | $508,817 | +16.2% | 30,001 | +1.4% | 0.00% | 0.0% |
| Q3 2022 | $438,000 | -7.4% | 29,584 | -1.6% | 0.00% | 0.0% |
| Q2 2022 | $473,000 | -35.9% | 30,054 | +9.7% | 0.00% | 0.0% |
| Q1 2022 | $738,000 | -31.7% | 27,391 | -6.2% | 0.00% | 0.0% |
| Q4 2021 | $1,081,000 | -21.0% | 29,197 | +1.9% | 0.00% | -50.0% |
| Q3 2021 | $1,368,000 | +38.7% | 28,640 | -1.7% | 0.00% | +100.0% |
| Q2 2021 | $986,000 | -21.4% | 29,123 | -4.1% | 0.00% | -50.0% |
| Q1 2021 | $1,254,000 | -13.2% | 30,375 | -8.8% | 0.00% | 0.0% |
| Q4 2020 | $1,444,000 | +38.7% | 33,291 | +37.1% | 0.00% | 0.0% |
| Q3 2020 | $1,041,000 | +13.3% | 24,275 | +23.5% | 0.00% | 0.0% |
| Q2 2020 | $919,000 | – | 19,661 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 208,886 | $5,337,037 | 1.71% |
| Portolan Capital Management | 276,505 | $7,064,703 | 0.66% |
| Nikko Asset Management Americas, Inc. | 1,388,574 | $35,422,523 | 0.42% |
| Green Alpha Advisors, LLC | 21,538 | $550,296 | 0.42% |
| SummerHaven Investment Management, LLC | 22,326 | $570,429 | 0.42% |
| ARK Investment Management | 1,901,546 | $48,584,508 | 0.37% |
| Granahan Investment Management | 398,862 | $10,190,924 | 0.36% |
| FEDERATED HERMES, INC. | 4,711,512 | $120,379,132 | 0.32% |
| Woodline Partners LP | 1,069,814 | $27,333,748 | 0.32% |
| Diametric Capital, LP | 26,130 | $667,621 | 0.28% |